BlackRock’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $213M | Buy |
6,736,939
+225,066
| +3% | +$7.11M | ﹤0.01% | 1582 |
|
|
2025
Q1 | $216M | Sell |
6,511,873
-456,224
| -7% | -$15.1M | ﹤0.01% | 1553 |
|
|
2024
Q4 | $240M | Buy |
6,968,097
+1,312,107
| +23% | +$45.1M | ﹤0.01% | 1562 |
|
|
2024
Q3 | $226M | Sell |
5,655,990
-179,253
| -3% | -$7.17M | ﹤0.01% | 1575 |
|
|
2024
Q2 | $176M | Sell |
5,835,243
-87,518
| -1% | -$2.64M | ﹤0.01% | 1682 |
|
|
2024
Q1 | $199M | Sell |
5,922,761
-80,566
| -1% | -$2.71M | ﹤0.01% | 1644 |
|
|
2023
Q4 | $194M | Sell |
6,003,327
-129,160
| -2% | -$4.17M | ﹤0.01% | 1650 |
|
|
2023
Q3 | $201M | Buy |
6,132,487
+382,009
| +7% | +$12.5M | 0.01% | 1537 |
|
|
2023
Q2 | $202M | Buy |
5,750,478
+790,338
| +16% | +$27.8M | 0.01% | 1561 |
|
|
2023
Q1 | $162M | Buy |
4,960,140
+90,358
| +2% | +$2.95M | ﹤0.01% | 1687 |
|
|
2022
Q4 | $268M | Buy |
4,869,782
+67,669
| +1% | +$3.73M | 0.01% | 1311 |
|
|
2022
Q3 | $213M | Buy |
4,802,113
+829,234
| +21% | +$36.7M | 0.01% | 1423 |
|
|
2022
Q2 | $194M | Buy |
3,972,879
+139,960
| +4% | +$6.83M | 0.01% | 1548 |
|
|
2022
Q1 | $186M | Buy |
3,832,919
+93,153
| +2% | +$4.53M | 0.01% | 1710 |
|
|
2021
Q4 | $159M | Buy |
3,739,766
+2,125,593
| +132% | +$90.6M | ﹤0.01% | 1890 |
|
|
2021
Q3 | $61.9M | Buy |
1,614,173
+309,428
| +24% | +$11.9M | ﹤0.01% | 2488 |
|
|
2021
Q2 | $36.8M | Buy |
1,304,745
+1,006,289
| +337% | +$28.4M | ﹤0.01% | 2853 |
|
|
2021
Q1 | $9.86M | Buy |
298,456
+12,895
| +5% | +$426K | ﹤0.01% | 3525 |
|
|
2020
Q4 | $10.3M | Buy |
285,561
+188,358
| +194% | +$6.81M | ﹤0.01% | 3276 |
|
|
2020
Q3 | $3.3M | Buy |
+97,203
| New | +$3.3M | ﹤0.01% | 3652 |
|